Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Rising Complications of Biostimulator Injections in Brazil: Mycobacterial Infections, Vascular Alopecia, and Late-Onset Nodules
Description
The talk reviewed rising complications from collagen biostimulator injections in Brazil, emphasizing an apparent increase in non-tuberculous mycobacterial infections, vascular compromise leading to alopecia, and late-onset nodules, especially as injections are increasingly performed by non-physicians and in new anatomical areas such as the temporal region. A representative mycobacterial case involved rapid progression after calcium hydroxylapatite injection, ultrasound findings suggestive of infection, delayed culture positivity, and improvement only after combined systemic therapy plus ultrasound-guided drainage and source control. Another case showed early vascular injury after temporal injection that was treated aggressively with hyaluronidase, hyperbaric oxygen, anticoagulation, and steroids, yet still resulted in delayed scalp alopecia, highlighting the need for rapid intervention. The lecture also described a growing series of delayed nodules, particularly with PLLA biostimulators, where ultrasound helped confirm solid subcutaneous lesions; refractory cases responded well to oral tofacitinib, which the group reported using successfully in more than 12 patients. The presentation concluded with key recommendations: strict aseptic technique and hygiene to prevent infection, early recognition and treatment of vascular events to avoid alopecia, timely diagnosis of nodules to prevent fibrosis, and adherence to evidence-based protocols to improve patient safety and guide future research.
View moreConclusions
- Biostimulator injections are associated with a rising burden of complications, especially mycobacterial infections, vascular compromise leading to alopecia, and late-onset nodules.
- Non-tuberculous mycobacterial infections should be suspected when post-injection lesions are rapidly progressive, inflammatory, and show characteristic ultrasound findings such as multiloculated collections and fistulous tracts.
- Delayed microbiologic identification is common in atypical mycobacterial infections, so early recognition and prompt referral are critical to avoid prolonged morbidity.
- Effective treatment of infectious complications usually requires both systemic antimicrobials and source control, including ultrasound-guided drainage and disruption of biofilm.
- Vascular compromise after temporal-region biostimulator injections can cause secondary hair loss, and even aggressive early treatment may not fully prevent delayed follicular ischemic damage.
- Late-onset nodules are becoming more frequent as biostimulator use expands and non-physicians perform more procedures.
- Ultrasound helps distinguish late-onset nodules as well-defined solid subcutaneous lesions and supports diagnosis when clinical findings are ambiguous.
- Refractory late-onset nodules may respond well to oral tofacitinib, with the presentation suggesting it is a promising option for selected cases.
- Unusual inflammatory reactions after blended or combined biostimulator treatments can be severe and may not improve with antibiotics alone.
- Patient safety depends on strict aseptic technique, early diagnosis, evidence-based protocols, and timely intervention to prevent long-term sequelae and fibrosis.
- Ultrasound-Based Differentiation of Esthetic Abscess: Insights From Clinical Practice. J Ultrasound Med. PMID and DOI visible.
- Alopecia as a Complication of Hyaluronic Acid Fillers and Collagen Biostimulators: A Case Series.
- Solid Nodules after Poly-L-Lactic Acid Injection: A study of 90 Patients.
- Successful Treatment of Cutaneous Foreign Body Granuloma with JAK Inhibitor Abrocitinib and Prednisone: A Case Report.#10.2147/ccid.s522469